Browse by Medical Category
Lab Phone: 617-726-5904
Neurology Access Center 1-855-644-6387
Pediatric Epilepsy: 617-726-6540
Dr. Cole's current research is focused on advanced neuroimaging techniques and clinical research.
Dr. Cole has published extensively in clinical neurology, epilpesy, and basic neuroscience. In addition to research and clinical work, Dr. Cole lectures frequently throughtout the United States and internationally, and has been a visiting professor at numerous institutions in the U.S.A. and abroad.
Andrew J. Cole, MD
Visit the Research page of the Epilepsy Service website for information about studies that are currently enrolling.
Functional MRI of language (Plasticity of Language Cortex)
Principle Investigator: Andrew Cole, MDCo-Principle Investigator: Bradley R. Buchbinder, MD, Radiology
Advanced neuroimaging and MEG studies
Principle Investigator: Andrew Cole, MDCo-Principle Investigator: Steve Stufflebeam, MD, Radiology
Clinical Trials Staus Updates - Closed to Enrollment
RNS™ System Long-term Treatment Clinical Investigation (Neuropace)
The responsive-neurostimulator (RNS) long-term treatment study is investigating how well the RNS™ system, a surgically implanted device, works in patients over an extended period of time as treatment for partial onset seizures. In order to be eligible for this study all subjects must have completed participation in the initial trial of this device, RNS™ System Pivotal Clinical Investigation which began at MGH in 2005.
The RNS™ System (made by Neuropace Inc.) is designed to reduce the frequency and severity of medically uncontrolled partial onset seizures. The RNS device has a small battery for power and a microprocessor that detects (senses) and stores electrical activity from the brain. When a seizure is detected, it responds by sending electrical stimulation through leads (tiny wires with electrodes) to a small part of the patient's brain to stop the seizure. This type of treatment is called responsive stimulation, but it is not yet known if it will work for the treatment of epilepsy.
Principle Investigator: Andrew Cole, MDResearch Coordinator: Samantha Donovan firstname.lastname@example.orgFor more information about the trial visit our sponsor’s website www.neuropace.com
Does memantine improve verbal memory task performance in patients with localization-related epilepsy and memory dysfunction? A randomized, double-blind, placebo-controlled trial.
Many patients with epilepsy have memory deficits. Unfortunately, the treatment options for memory dysfunction in patients with epilepsy are limited. We are conducting a study to evaluate the effects of memantine, a medication used for the treatment of Alzheimer’s Disease, for the treatment of memory dysfunction in subjects with localization-related seizures.
Principle Investigator: Beth Leeman email@example.comResearch Coordinator: Samantha Donovan firstname.lastname@example.org
Read about and apply for residency, fellowship and observership programs at http://www.massgeneral.org/neurology/education.
Apply for temporary positions (summer interns) through the Bulfinch Temporary Service Web site at http://www.massgeneral.org/careers/temporary.aspx. Search for all opportunities using ID# 2200484.
All applicants should register with the Mass General Careers Web site at http://www.massgeneral.org/careers/viewall.aspx. Request a list of current open positions at email@example.com.
Dr. Cole's publications are available via the following links:
Epilepsy Service Publications
Wang Ambulatory Care Center
Consultation Second Opinion and Record Review
Epilepsy Monitoring Unit, First Seizure Clinic, Epilepsy Surgery
Phone: 617-726-6540Pediatric Epilepsy website
Andrew J. Cole, MDDirector, Mass General Hospital Epilepsy ServiceChief, Mass General Epilepsy Research LaboratoryMassachusetts General Hospital55 Fruit StreetBoston, MA 02114
Samantha R. DonovanClinical Research Coordinator
Patient Frequently Asked Questions Download FAQ PDFQ: What is your office contact information?A: Phone: 617-726-3311Fax: 617-726-9250Q: Where is the clinic location?A: Wang Building, Floor 8, Suite 835Q: What is your mailing address?A: Attn: Epilepsy UnitWang 73555 Fruit StreetBoston, MA 02114Q: What is required in order to schedule a new patient appointment?A: 2-3 most recent offices notes from local NeurologistMost recent Brain MRI report (you will need to hand carry CD to appointment)Most recent EEG report (you will need to hand carry CD to appointment)Q: How can I obtain a copy of my medical records from the Epilepsy Unit? A: You will need to complete the MGH Release of Information form and either fax or mail it back to our office. The release form can be found here.Q: What is my doctor’s NPI number for an insurance referral?A: Dr. Andrew Cole: 1043201502Dr. Daniel Hoch: 1396727327Dr. Sydney Cash: 1265415616Dr. Jay Pathmanathan: 1164545299Dr. Michael Brandon Westover: 1184653487Dr. Lidia Veras Rocha de Moura: 1952664443Dr. Deirdre O’Rourke: 1194092858Dr. Arash Hadipour-Niktarash: 1265669253Dr. Ammar Kheder: 1770925976Dr. Nigel Pedersen: 1801023742Dr. Aaron Struck: 1922238336Dr. Gina Deck: 1255642286Dr. Alice Lam: 1184949224Dr. Rodrigo Garcia Zepeda: 1982923785Tara Jennings, NP: 1508046723Q: Where do I have my PCP fax my insurance referral to?A: Referrals Office fax: 781-960-1265Q: How do I know if my insurance will cover my visit? A: Please call your insurance company to verify that your appointment or test will be covered. You can also contact our Financial Access Unit at 617-726-6828.Q: How do I update my demographic and insurance information?A: Please contact our Registration and Referrals Center at 866-211-6588Q: How long will it take for me to receive my test results and how will they be communicated to me? A: For lab work, radiology results, and EEG results please contact the office at least 48 hours after the test and we can let you know if the results are finalized. If they are, we will ask your provider to contact you to discuss the results with you.
Back to Top